What are the causes of hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hyperkalemia is primarily caused by kidney dysfunction, which impairs potassium excretion, and can also be caused by medications that affect potassium balance, such as ACE inhibitors, ARBs, potassium-sparing diuretics, and NSAIDs, as well as adrenal disorders and excessive potassium intake. The causes of hyperkalemia can be categorized into several key areas, including:

  • Kidney dysfunction, such as acute or chronic kidney disease, which impairs the body's ability to excrete potassium 1
  • Medications that affect potassium balance, including:
  • ACE inhibitors and ARBs, which can increase potassium levels by reducing aldosterone production 1
  • Potassium-sparing diuretics, such as spironolactone, which can increase potassium levels by reducing potassium excretion 1
  • NSAIDs, which can increase potassium levels by reducing potassium excretion 1
  • Adrenal disorders, such as Addison's disease, which can reduce aldosterone production and lead to hyperkalemia 1
  • Excessive potassium intake, including:
  • Potassium supplements 1
  • Salt substitutes, such as those containing potassium chloride 1
  • Certain foods, such as bananas, melons, and orange juice, which are high in potassium 1
  • Other contributors, including:
  • Massive cell destruction, such as in tumor lysis syndrome, rhabdomyolysis, or severe burns, which can release intracellular potassium into the bloodstream 1
  • Acidosis, which can drive potassium out of cells and into the bloodstream 1
  • Certain medications, such as beta-blockers and digoxin, which can interfere with cellular potassium uptake 1
  • Pseudohyperkalemia, a falsely elevated potassium reading, which can occur with hemolysis during blood collection, extreme thrombocytosis, or leukocytosis 1

It is essential to identify and address the underlying cause of hyperkalemia to prevent cardiac complications and other adverse outcomes. Management typically involves restricting dietary potassium, administering calcium gluconate, insulin with glucose, beta-agonists, or dialysis to rapidly lower potassium levels, and addressing the underlying cause of the hyperkalemia 1.

From the Research

Causes of Hyperkalemia

The causes of hyperkalemia can be attributed to various factors, including:

  • Medications such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) that can increase serum potassium levels 2, 3, 4, 5
  • Renal insufficiency or chronic kidney disease, which can lead to impaired potassium excretion 2, 3, 6, 4, 5
  • Congestive heart failure, which can increase the risk of hyperkalemia 2, 6
  • Excessive potassium intake from diet, supplements, or drugs 4
  • Certain medical conditions, such as diabetes mellitus and ischemic heart disease 5

Risk Factors for Hyperkalemia

Several risk factors can increase the likelihood of developing hyperkalemia, including:

  • Age over 70 years 2
  • Serum urea nitrogen level higher than 6.4 mmol/L (18 mg/dL) or creatinine level higher than 136 mumol/L (1.5 mg/dL) 2
  • Use of long-acting ACE inhibitors 2
  • Concurrent use of loop or thiazide diuretic agents, which can reduce the risk of hyperkalemia 2
  • Chronic kidney disease stage 4 or 5, which can increase the prevalence of hyperkalemia 5

Clinical Context and Hyperkalemia

The clinical context in which hyperkalemia develops is important in determining patient outcome, and factors such as physiologic adaptation, structural cardiac disease, medication use, and degree of concurrent illness can influence the risk of toxicity 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Hyperkalemia: An Update for the Internist.

The American journal of medicine, 2015

Research

[Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018

Research

How Dangerous Is Hyperkalemia?

Journal of the American Society of Nephrology : JASN, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.